Universal Screening for Type 1 Diabetes: Its Time has Come?
Universal screening for type 1 diabetes (T1D) is a priority for Breakthrough T1D, but the cost versus benefits remain unclear.…
Breakthrough T1D and Gore Invest in Development of Implantable Insulin Delivery System
PhysioLogic Devices, a Breakthrough T1D-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to…
Can Prozac Prevent Severe Low Blood Sugar?
Low blood sugar, called hypoglycemia, occurs in over 90 percent of people with type 1 diabetes (T1D). It can usually…
FDA Grants Breakthrough Device Status: iLet Bionic Pancreas
Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the…
Top 10 T1D Breakthroughs of the Year
There’s 11 days left in 2019, but what did Breakthrough T1D see this year that said “breakthrough”? This top 10…
One Scientist, One Goal: To End Diabetic Eye Disease, Forever
It’s a devastating statistic: More than 90% of people with type 1 diabetes (T1D) develop diabetic eye disease within 20…
FDA Authorizes a Second Artificial Pancreas System
The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced…
Two Scientists, Finding Ways to Prevent Diabetic Kidney Disease
It’s a devastating statistic: 1 in 4 people with type 1 diabetes (T1D) are affected by kidney disease. But thanks…
The Promising Clinical Trials in the Breakthrough T1D Pipeline
As the leading global funder of type 1 diabetes (T1D) research, Breakthrough T1D invests in the most promising research studies…
One Less Device: Combining CGM and Insulin Infusion
Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and…
